Olaparib
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Olaparib and local guidelines before prescribing.
PARP inhibitor
Mechanism
PARP inhibitor.
Uses
BRCA-mutated ovarian, breast, prostate and pancreatic cancer.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Anaemia, nausea, fatigue, myelodysplasia, pneumonitis, VTE.
Interactions
CYP3A4 inhibitors and inducers.
Contraindications and cautions
Pregnancy
Monitoring
FBC
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Reduce dose in moderate renal impairment
Overdose and reversal
Supportive
Special advice
FBC monthly; confirm BRCA status.
More from the textbook: uses, cautions and other points
- Olaparib maintenance for BRCA mutations.
Gastroenterology: Pancreas and Biliary - Olaparib | Maintenance in BRCA-mutated metastatic pancreatic cancer.
Gastroenterology: Pancreas and Biliary - PARP inhibitors (BRCA-mutant ovarian, breast, prostate and pancreatic cancer - olaparib, niraparib): Anaemia, nausea, fatigue; rare MDS and AML.
Oncology: Principles - PARP inhibitors (olaparib) for BRCA or other DNA-repair mutations.
Oncology: Urology and Genital cancers - Capecitabine or olaparib (BRCA) for residual disease.
Oncology: Breast and Gynae Cancers - PARP inhibitors (olaparib, niraparib) - especially with BRCA mutations or homologous recombination deficiency.
Oncology: Breast and Gynae Cancers - Olaparib / niraparib | PARP inhibitors - ovarian maintenance, BRCA breast cancer; anaemia, rare MDS.
Oncology: Breast and Gynae Cancers - Treatment implications - PARP inhibitors (olaparib, niraparib) for BRCA-associated ovarian, breast, prostate and pancreatic cancer; platinum sensitivity; surgical choices (mastectomy vs breast conservation; contralateral surgery).
Clinical Genetics: Cancer genetics and inherited cardiovascular conditions
Where it is discussed in the book
- Gastroenterology: Pancreas and Biliary (2 mentions)
- Oncology: Principles (1 mention)
- Oncology: Urology and Genital cancers (1 mention)
- Oncology: Breast and Gynae Cancers (3 mentions)
- Clinical Genetics: Cancer genetics and inherited cardiovascular conditions (1 mention)
- Cell Biology: Molecular biology, gene expression and laboratory techniques (2 mentions)